Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement
Phase 3
Active, not recruiting
- Conditions
- Post Operative Pain
- Interventions
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Arthritis Innovation Corporation
- Target Recruit Count
- 151
- Registration Number
- NCT05603832
- Locations
- 🇺🇸
Woodland International Research Group, Little Rock, Arkansas, United States
🇺🇸Phoenix Clinical Research, Tamarac, Florida, United States
🇺🇸The Orthopedic Center, Tulsa, Oklahoma, United States
Safety of F14 Following Total Knee Replacement
Phase 2
Suspended
- Conditions
- Analgesia
- Interventions
- Drug: F14 (sustained release celecoxib)
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Arthritis Innovation Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT04860635
- Locations
- 🇺🇸
Panorama Orthopedics & Spine Center, Denver, Colorado, United States
🇺🇸Endeavor Clinical Trials, San Antonio, Texas, United States
Safety and Activity of F14 for Management of Pain Following Total Knee Replacement
Phase 2
Completed
- Conditions
- Total Knee ReplacementPostoperative Pain
- Interventions
- Drug: F14 (celecoxib)
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- Arthritis Innovation Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT03541655
- Locations
- 🇺🇸
Panorama Orthopedics & Spine Center, Denver, Colorado, United States
🇺🇸Midwest Clinical Research Center, Dayton, Ohio, United States
🇺🇸Endeavor Clinical Trials, San Antonio, Texas, United States
News
No news found